SEC Form 4 · accession 0001140361-16-069482
Opus Genetics, Inc. · IRD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard J Rodgers
Director
Period of report
Jun 9, 2016
Accepted (ET)
Jun 10, 2016 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001228627
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.28 | Jun 9, 2016 | A | 225,000 | A | Jun 9, 2017 | Jun 9, 2026 | Common Stock | 225,000 | 225,000 | D |